Brenda McGaha v. HHS - Tdap, shoulder injury related to vaccine administration (SIRVA) (2025)
Case summary [AI summaries can sometimes make mistakes]
On April 15, 2022, Brenda McGaha filed a petition seeking compensation after a tetanus, diphtheria, and acellular pertussis (Tdap) vaccine administered on December 13, 2019. She alleged a shoulder injury related to vaccine administration, either as a Table SIRVA or, in the alternative, as a caused-in-fact injury, with residual effects lasting more than six months.
Respondent denied that Ms. McGaha sustained a SIRVA Table injury, denied that the Tdap vaccine caused the alleged SIRVA or any other injury, and denied that her current condition was a sequela of a vaccine-related injury.
The public stipulation decision does not describe symptom onset, medical treatment, imaging, functional impact, experts, or a causation mechanism. On October 7, 2025, Chief Special Master Brian H.
Corcoran adopted the parties' joint stipulation. Ms.
McGaha received a lump sum of $17,500.00, paid through counsel's IOLTA account, representing all damages available under Section 15(a).
Theory of causation
Tdap vaccine, December 13, 2019, alleged Table SIRVA or caused-in-fact shoulder injury. COMPENSATED by stipulation. Respondent denied Table SIRVA, Tdap causation, and sequelae. Public decision/stipulation does not provide onset, clinical course, testing, experts, or mechanism. Award: $17,500 lump sum for all Section 15(a) damages, ACH to counsel IOLTA. Chief Special Master Corcoran October 7, 2025. Attorney Laura Levenberg, Muller Brazil; respondent Mary Eileen Holmes.
Source PDFs
USCOURTS-cofc-1_22-vv-00436